# Glyphic Biotechnologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glyphic-biotechnologies

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.glyphic.bio
- Total disclosed funding: $6M
- Latest round: Seed (Jul 8, 2021)
- Investors on record: 7

## About

Based in California, US, and founded in 2021, Glyphic Biotechnologies, Inc. operates as a biotechnology company that sequences proteins. The company was co-founded by CEO Mr. Joshua Yang and CTO Mr. Daniel Estandian. In February 2024, Glyphic Biotechnologies, Inc. raised USD 33.18 million in series A funding from unspecified investors. This round was part of a larger USD 52.92 million venture funding. The company will use the October 2025 funding to expand its business operations.

## Funding rounds

- Seed, Jul 8, 2021, $6M — OUP (Osage University Partners), ARTIS Ventures, Axial, Wing, Cantos Ventures, Civilization Ventures, OMX Ventures

## Investors

- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Seed
- ARTIS Ventures (https://capitalatlas.ai/funds/artis-ventures) — Seed
- Axial — Seed
- Wing (https://capitalatlas.ai/funds/wing) — Seed
- Cantos Ventures (https://capitalatlas.ai/funds/cantos-ventures) — Seed
- Civilization Ventures (https://capitalatlas.ai/funds/civilization-ventures) — Seed
- OMX Ventures (https://capitalatlas.ai/funds/omx-ventures) — Seed